Enzon Pharmaceuticals, Inc. (ENZN)

USD 0.1

(0.0%)

Market Cap (In USD)

7.42 Million

Revenue (In USD)

-

Net Income (In USD)

98 Thousand

Avg. Volume

71.1 Thousand

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
0.06-0.24
PE
-10.0
EPS
-0.01
Beta Value
0.483
ISIN
US2939041081
CUSIP
293904108
CIK
727510
Shares
74214600.0
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Richard L. Feinstein CPA
Employee Count
-
Website
https://www.enzon.com
Ipo Date
1984-02-15
Details
Enzon Pharmaceuticals, Inc., together with its subsidiaries, engages in marketing drug products. The company's marketed drug product is PegIntron. It also has a marketing agreement relating to Vicineum drug. The company was founded in 1981 and is headquartered in Cranford, New Jersey.